Portfolio 1 - New Portfolio
John Bender
Portfolio 1Individual Investor
Ranked #111,773 out of 858,896 TipRanks' Investors
Success Rate
132 out of 253
profitable transactions
profitable transactions
Average Return
54.68%
Average return
per transaction
per transaction
Share this portfolio:
Portfolio Gain
1-Month Return▼ 0.64%
6-Month Return▲ 7.06%
12-Month Return▲ 70.91%
YTD Return▲ 5.63%
Total Return▲ 237.89%
Best Trade
Bio
Income-focused Retirement Portfolio with speculative bio/pharma, EV and space positions
Performance
12.88%0-12.88%
▲ 12.88%
▲ 3.56%
▲ 9.74%
Sep 2025
▲ 10.96%
▲ 2.38%
▲ 8.68%
Oct 2025
▼ 3.68%
▲ 0.19%
▼ 2.49%
Nov 2025
▼ 0.10%
▲ 0.08%
▲ 0.20%
Dec 2025
▲ 4.06%
▲ 1.47%
▲ 10.33%
Jan 2026
▼ 1.12%
▼ 0.86%
▼ 3.24%
Feb 2026
▲ 0.60%
▼ 4.94%
▼ 4.97%
Mar 2026
▲ 4.89%
▲ 4.48%
▲ 4.12%
Apr 2026
▲ 12.88%▲ 3.56%▲ 9.74%
▲ 10.96%▲ 2.38%▲ 8.68%
▼ 3.68%▲ 0.19%▼ 2.49%
▼ 0.10%▲ 0.08%▲ 0.20%
▲ 4.06%▲ 1.47%▲ 10.33%
▼ 1.12%▼ 0.86%▼ 3.24%
▲ 0.60%▼ 4.94%▼ 4.97%
▲ 4.89%▲ 4.48%▲ 4.12%
Recent Activity
Dynavax
―
▲ 38.72%
3
Close
Feb 09, 2026
23andMe Holding
―
▼ 94.27%
2
Close
Dec 05, 2025
Unity Biotechnology
―
▼ 98.04%
3
Close
Oct 01, 2025
DermTech
―
▼ 99.29%
3
Close
Aug 13, 2025
Intra-Cellular Therapies
―
▲ 488.44%
5
Close
Apr 01, 2025
Terran Orbital Corp
―
▼ 83.89%
2
Close
Aug 21, 2024
Atara Biotherapeutics
―
▼ 94.80%
4
Close
Feb 18, 2024
Agenus
―
▼ 83.14%
3
Close
Feb 18, 2024
Carnival
―
▼ 5.19%
4
Close
Feb 18, 2024
ImmunoGen
―
▲ 538.65%
4
Close
Feb 18, 2024
Caribou Biosciences
―
▼ 29.06%
2
Close
Feb 18, 2024
Crinetics Pharmaceuticals
―
▲ 104.88%
2
Close
Feb 18, 2024
Cyclo Therapeutics
―
▼ 6.88%
2
Close
Feb 18, 2024
Precision BioSciences
―
▼ 71.79%
3
Close
Feb 18, 2024
Capital Southwest
―
▲ 45.75%
2
Close
Feb 18, 2024
Axsome Therapeutics
―
▲ 105.56%
3
Close
Feb 18, 2024
Spyre Therapeutics
―
▼ 9.83%
2
Close
Feb 18, 2024
Allogene Therapeutics
―
▼ 38.85%
3
Close
Feb 18, 2024
Alpine Immune Sciences
―
▲ 428.93%
2
Close
Feb 18, 2024
Altimmune
―
▲ 23.95%
3
Close
Feb 18, 2024